Comparing Latanoprost and Dorzolamide/Timolol for Glaucoma Treatment
Author Information
Author(s): Sultan Pinar, Gungel Hulya, Ciftci Furkan
Primary Institution: University of Health Sciences Istanbul Training and Research Hospital
Hypothesis
How do latanoprost and dorzolamide/timolol fixed combination therapy compare in lowering intraocular pressure in patients with pseudoexfoliative glaucoma based on glaucoma stage?
Conclusion
Both latanoprost and dorzolamide/timolol fixed combination are effective treatments for newly diagnosed pseudoexfoliative glaucoma, with dorzolamide/timolol showing greater efficacy in early-stage cases.
Supporting Evidence
- The mean intraocular pressure difference was significantly greater in patients with early-stage glaucoma treated with dorzolamide/timolol.
- Both treatments significantly reduced intraocular pressure, but dorzolamide/timolol was more effective in early-stage cases.
- Statistical analyses showed no significant differences in baseline intraocular pressure between the two treatment groups.
Takeaway
This study looked at two eye drops used to treat a type of glaucoma. One drop worked better than the other for patients with early-stage glaucoma.
Methodology
The study retrospectively assessed data from 32 patients with pseudoexfoliative glaucoma treated with either latanoprost or dorzolamide/timolol, comparing intraocular pressure before and after treatment.
Potential Biases
Potential bias due to the retrospective nature and differences in prior cataract surgery between groups.
Limitations
The study had a retrospective design and a small, heterogeneous sample size.
Participant Demographics
Mean age was 69 years, with 65.6% in early-stage and 34.4% in moderate-advanced stage glaucoma.
Statistical Information
P-Value
p=0.033
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website